Provided by Tiger Fintech (Singapore) Pte. Ltd.

Karyopharm Therapeutics

7.09
-0.2700-3.67%
Volume:107.24K
Turnover:791.36K
Market Cap:60.76M
PE:-0.51
High:7.83
Open:7.20
Low:7.04
Close:7.36
Loading ...
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Correspondence

Form CORRESP - Correspondence
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report